Scientific Publications 2012

• Axel Finckh, Burkhard Möller, Jean Dudler, Ulrich A Walker, Diego Kyburz, Cem Gabay on behalf of the physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis, "Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists", Ann Rheum Dis, March 2012.
• Delphine S Courvoisier, Thomas Agoritsas, Jérôme Glauser, Kaleb Michaud, Fred Wolfe, Eva Cantoni, Thomas V Perneger, Axel Finckh, "Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis." Arthritis care & research, Feb. 2012; 64(2):190-6
• Sophie Martin Du Pan, Almut Scherer, Cem Gabay, Axel Finckh1, "Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients", Ann Rheum Dis, Jan. 2012.

    Scientific Publications 2011

• Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland M, Tarp U, Gabay C*, Van Riel P LCM, Nordstroem DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, Van Vollenhoven RF; *for the SCQM registry, "Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries". Ann Rheum Dis 2011; 70: 1575-1580.
• Kyburz D, Gabay C, Michel BA, Finckh A; for the physicians of the SCQM-RA, "The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study". Rheumatology (Oxford) 2011 Jan 21. [Epub ahead of print].
• Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF., "Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.", Ann Rheum Dis. 2011 Sep;70(9):1575-80
• Katerina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, Galina Lukina, Merete Lund Hetland, Ulrik Tarp, Piet L C M van Riel, Dan C Nordström, Juan Gomez-Reino, Karel Pavelka, Matija Tomsic, Tore K Kvien, Ronald F van Vollenhoven, Cem Gabay, "Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration", Ann Rheum Dis 2011 Oct 4.
• Zufferey,  Pascal, Mouly Jr.,  Cecile, Ziswiler,  Hans Rudolf, Dudler,  Jean, "Subclinical Peripheral Synovitis Detected by ultrasound In Patients with Axial Spondyloarthritis.", Poster presentation (Nr. 499), Arthritis & Rheumatism, Volume 63, 
November 2011 Abstract Supplement.
• Scherer,  Almut, Weber,  Ulrich, Exer,  Pascale, Bernhard,  Juerg, Dudler,  Jean, Tamborrini,  Giorgio, Weiss,  Bettina, "Rheumatologist's Expert Opinion Is An Important Determinant of Tumor Necrosis Factor Blocking Agent Prescription in Axial Spondyloarthritis: Results From the Swiss Clinical Quality Management Axial Spondyloarthritis Cohort.", PosterPoster presentation (Nr. 527), Arthritis & Rheumatism, Volume 63, 
November 2011 Abstract Supplement.
• Michael J. Nissen, Adrian Ciurea, Burkhard Moller, Juerg Bernhard, Ruediger Mueller, Bettina Weiss, Giorgio Tamborrini, Almut Scherer, Cem Gabay and Axel Finckh, "The Effect of DMARD Co-Therapy on Anti-TNF Drug Retention in 1630 Spondyloarthritis Patients", Oral Presentation (Nr. 2637).
  

   Scientific Publications 2010

• Finckh A, Scherer A, Lubbeke A, Schwarz H, and Gabay C, "The impact of body weight on the progression of radiographic joint damage in Rheumatoid Arthritis patients". Oral presentation at the 2010 ACR/ARHP Annual Scientific Meeting, Atlanta, November 7-12, 2010.
• Curtis JR, Jain A, Askling J, Bridges SL Jr, Carmona L, Dixon W, Finckh A, Hyrich K, Greenberg JD, Kremer J, Listing J, Michaud K, Mikuls T, Shadick N, Solomon DH, Weinblatt ME, Wolfe F, Zink A., "A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries". Semin Arthritis Rheum. 2010 Aug;40(1):2-14.e1.
• Walker UA, Courvoisier DS, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A, "Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion". Rheumatology 2010 Aug 17; Epub ahead of print.
• B. Möller, D. Wisler, S. Adler, A. Scherer, P.M. Villiger, A. Finckh; physicians of SCQM, "Renal safety of nonsteroidal antirheumatic drugs (NSAIDS) is better than their image. ". Oral presentation at the 2010 EULAR Annual Scientific Meeting, Rome, June 16-19, 2010
• K. Chatzidionysiou, C. Gabay, J. Gomez-Reino, M.L. Hetland, T.K. Kvien, E. Lie, G. Lukina, E. Nasonov, D. Nordstrom, K. Pavelka, U. Tarp, M. Tomsic, P. LMC van Riel , R.F. van Vollenhoven, "Effectiveness of different DMARD co-therapies in Rituximab treated rheumatoid Arthritis (RA) patients - Results of a one-year follow up study from the CERRERA collaboration.: Oral presentation at the 2010 EULAR Annual Scientific Meeting, Rome, June 16-19, 2010.
• Finckh A, Dudler J, Wermelinger F, Ciurea A, Kyburz D, Gabay C, Bas S; physicians of SCQM, "Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.". Joint Bone Spine. 2010 Jul;77(4):313-8. Epub 2010 May 14.
• Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C, "Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent?". Ann Rheum Dis. 2010 Feb; 68(2): 387-93. Epub 2009 May 4.
• Nissen MJ, Gabay C, Scherer A, Finckh A, on behalf of the physicians of the SCQM-RA. "The effect of alcohol on radiographic progression in rheumatoid arthritis", Arthritis Rheum. 2010 Mar 8. [Epub ahead of print].

Scientific Publications 2009

• Finckh A, Scherer A, George Reed PhD, Jeffrey Greenberg MD, MPH, Lubbeke A, Schwarz H, Gabay C, Joel Kremer, MD, "Obesity and RA Disease Severity: A Comparison Between European and American RA Patients". Poster presentation at the 2009 ACR/ARHP Annual Scientific Meeting, Philadelphia, PA, October 16-21, 2009.
• Du Pan SM, Dehler S, Ciurea A, Ziswiler HR, Gabay C, Finckh A, "Comparison of drug retension rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis". Ann Rheum Dis. 2009 May 15; 61(5): 560-9.
  

• Finckh A, Dehler S, Gabay C; SCQM doctors. "The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study." Ann Rheum Dis. 2009 Jan;68(1):33-9.
  

Scientific Publications 2007

• Finckh A , Dehler S, Costenbader K, Gabay C, on behalf of the SCQM-RA,  "Cigarette smoking and radiographic progression in rheumatoid arthritis". Annals of the Rheumatic Diseases 2007; 66; 1066-1071.
• Finckh A, Ciurea A, Brulhart L, Revaz S, Möller B, Dehler S, Kyburz D, Dudler J, Gabay C, on behalf of the SCQM-RA, "B-cell depletion may be more effective than switching to an alternative anti-TNF agent in RA patients with inadequate response to anti-TNF agents". Arthritis and Rheumatism 2007; May 2007; 56(5), 1417-23.
• Genevay S*, Finckh A*, Ciurea A, Chamot AM, Kyburz D, Gabay C, for the physician of the SCQM-RA (* Authors have equally contributed), "Tolerance and effectiveness of anti-TNF-a therapies in elderly patients with rheumatoid arthritis. A population based cohort study". Arthritis and Rheumatism (AC&R) 2007 Apr 30; 57(4):679-685.

 

Scientific Publications 2006

• Finckh A, Simard J, Gabay C, Guerne PA, for the physician of the SCQM-RA,  "Evidence for differential acquired drug resistance to anti-TNF agents in rheumatoid arthritis". Annals of Rheumatic Diseases 2006 Jun; 65(6):746-52.
• Finckh A, Simard JF, Huang J, Duryea J, Liang M, Daneel S, Forster A, Gabay C, Guerne PA., "The effectiveness of anti-TNF therapy in preventing progressive radiographic joint damage in rheumatoid arthritis. A population based study". Arthritis and Rheumatism, 2006 Jan; 54(1):54-9. Pfizer Price 2006 for medical research: Clinical rheumatology and immunology.
• Genta MS, Kardes H, Gabay C., "Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community". Joint Bone Spine, 2006 Jan; 73(1):51-6.